Industry · SIC 2836
Biological Products, (No Diagnostic Substances)
454 tracked issuers filing with the SEC under this industry classification.
Issuers
454
Recent filings
40
SIC code
2836
Industry overview
Biological Products, (No Diagnostic Substances)
SIC 2836 covers makers of biological products excluding diagnostics, encompassing vaccines, monoclonal antibodies, therapeutic proteins, plasma derivatives, and emerging cell and gene therapies supplied to hospitals, specialty clinics, government health agencies, global health organizations, and biopharma partners. Companies operate under tight FDA/EMA controls, GMP and biosafety requirements, cold-chain and raw-material constraints, patent expirations, and pricing and reimbursement scrutiny. In 2024-2025 the industry is scaling mRNA platforms beyond COVID, pushing personalized cell therapies and gene-editing candidates through pivotal trials, and adopting AI-driven discovery, digital manufacturing, and greener supply chains while reshoring critical inputs to bolster resilience. Core services include contract development and manufacturing for biologics, immunology, oncology, and rare disease indications, alongside lifecycle management and pharmacovigilance. Growth is tempered by regulatory review times, CMC complexity, and competition from biosimilars, but demand remains supported by expanding immunization programs and specialty therapeutics. For the latest capital moves, trials, and compliance updates, view SEC filings on Earnings Feed.
Source: Earnings Feed research · Nov 23, 2025
Latest filings
- 144OCGNOcugen, Inc.7.3 KBSEC(opens sec.gov)
- S-1Bambusa Therapeutics, Inc.56.7 MBSEC(opens sec.gov)
- 8-KPCVXVaxcyte, Inc.2.1 MBSEC(opens sec.gov)
- 144TWSTTwist Bioscience Corp6.2 KBSEC(opens sec.gov)
- 8-KEXOZEXOZYMES INC.7.2 MBSEC(opens sec.gov)
- 8-KQNCXQuince Therapeutics, Inc.476.0 KBSEC(opens sec.gov)
- 8-KXFORX4 Pharmaceuticals, Inc175.4 KBSEC(opens sec.gov)
- 8-KVIRVir Biotechnology, Inc.242.4 KBSEC(opens sec.gov)
- 6-KVALNValneva SE40.5 KBSEC(opens sec.gov)
- S-1/AIambic Therapeutics, Inc.48.6 MBSEC(opens sec.gov)
- 8-KEDITEditas Medicine, Inc.292.6 KBSEC(opens sec.gov)
- 6-KARGXARGENX SE45.5 KBSEC(opens sec.gov)
- SCHEDULE 13G/ASRZNSurrozen, Inc./DE12.9 KBSEC(opens sec.gov)
- 144RLAYRelay Therapeutics, Inc.6.2 KBSEC(opens sec.gov)
- 6-KGNTAGenenta Science S.p.A.20.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/ABKHABlack Hawk Acquisition Corp12.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/AIMCRImmunocore Holdings plc11.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/AXFORX4 Pharmaceuticals, Inc11.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/AEIKNEikon Therapeutics, Inc.11.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ARGENREPLIGEN CORP11.7 KBSEC(opens sec.gov)
- 6-KALVOAlvotech16.6 KBSEC(opens sec.gov)
- 8-KBCDABioCardia, Inc.169.1 KBSEC(opens sec.gov)
- 8-KCEROCERO THERAPEUTICS HOLDINGS, INC.566.0 KBSEC(opens sec.gov)
- 8-KJSPRJasper Therapeutics, Inc.238.3 KBSEC(opens sec.gov)
- SCHEDULE 13G/AATYRaTYR PHARMA INC46.6 KBSEC(opens sec.gov)
- 8-KQNCXQuince Therapeutics, Inc.567.7 KBSEC(opens sec.gov)
- 144CRSPCRISPR Therapeutics AG5.5 KBSEC(opens sec.gov)
- 144ADPTSEC(opens sec.gov)
- 144ARTVSEC(opens sec.gov)
- 144RLAYRelay Therapeutics, Inc.7.1 KBSEC(opens sec.gov)
- 144MGTXMeiraGTx Holdings plc5.6 KBSEC(opens sec.gov)
- 8-KCRBUCaribou Biosciences, Inc.190.3 KBSEC(opens sec.gov)
- 10-QBKHASEC(opens sec.gov)
- 8-KVIVSVivoSim Labs, INC.459.5 KBSEC(opens sec.gov)
- S-1PLURPluri Inc.358.4 KBSEC(opens sec.gov)
- 144RXRXSEC(opens sec.gov)
- 144RXRXSEC(opens sec.gov)
- 8-KRGENREPLIGEN CORP179.8 KBSEC(opens sec.gov)
- 8-KENTXEntera Bio Ltd.225.1 KBSEC(opens sec.gov)
- 6-KOKYOOKYO Pharma Ltd47.8 KBSEC(opens sec.gov)
Featured issuers
- 10X Capital Venture Acquisition Corp. IIICIK 0001848948
- 4D Molecular Therapeutics, Inc.CIK 0001650648FDMT
- Abcam plcCIK 0001492074
- ABGENIX INCCIK 0001052837
- Ablynx NVCIK 0001617582
- Abpro Holdings, Inc.CIK 0001893219ABPO
- ACCELERON PHARMA INCCIK 0001280600
- Aceragen, Inc.CIK 0000861838
- ACESIS HOLDINGS CORP.CIK 0001955728
- Achilles Therapeutics plcCIK 0001830749
- Acorda Therapeutics, Inc.CIK 0001008848
- Acumen Pharmaceuticals, Inc.CIK 0001576885ABOS
Classification
- SIC code
- 2836
- Total issuers
- 454
- Recent filings
- 40